Full Spectrum Flow Cytometry as a Powerful Technology for Cancer Immunotherapy Research
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Full Spectrum Flow Cytometry as a Powerful Technology for Cancer Immunotherapy Research
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-29
DOI
10.3389/fmolb.2020.612801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment
- (2020) Min Yang et al. OncoImmunology
- High-Dimensional Data Analysis Algorithms Yield Comparable Results for Mass Cytometry and Spectral Flow Cytometry Data
- (2020) Laura Ferrer-Font et al. CYTOMETRY PART A
- Phenotypic Analysis of the Mouse Hematopoietic Hierarchy Using Spectral Cytometry: From Stem Cell Subsets to Early Progenitor Compartments
- (2020) Michael Solomon et al. CYTOMETRY PART A
- Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity
- (2020) Xuan Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cancer Cell–Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti–PD-1 Therapy in Lung Adenocarcinoma
- (2020) Amber M. Johnson et al. JOURNAL OF IMMUNOLOGY
- Thymic resident NKT cell subsets show differential requirements for CD28 co-stimulation during antigenic activation
- (2020) Susannah C. Shissler et al. Scientific Reports
- Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer
- (2020) Ramireddy Bommireddy et al. Vaccines
- Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19
- (2020) Aymeric Silvin et al. CELL
- DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
- (2020) Yonghan He et al. Journal of Hematology & Oncology
- Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation
- (2020) Kevin Louis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Senolytic CAR T cells reverse senescence-associated pathologies
- (2020) Corina Amor et al. NATURE
- Adjuvant-free nanofiber vaccine induces in situ lung dendritic cell activation and TH17 responses
- (2020) Youhui Si et al. Science Advances
- Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
- (2020) Julie E. Bauman et al. Cancers
- Evaluating spectral cytometry for immune profiling in viral disease
- (2020) Paula Niewold et al. CYTOMETRY PART A
- OMIP‐069 : Forty‐Color Full Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Major Cell Subsets in Human Peripheral Blood
- (2020) Lily M. Park et al. CYTOMETRY PART A
- Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection
- (2020) Tengfang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure
- (2020) Bo Zhou et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
- (2020) Harry Ho Man Ng et al. Journal for ImmunoTherapy of Cancer
- Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy
- (2020) Aaron J. Wilk et al. Blood Advances
- Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
- (2020) Lauren B. Rodda et al. CELL
- Spectral flow cytometry— Quo vadimus ?
- (2019) J. Paul Robinson CYTOMETRY PART A
- Rigor and Reproducibility of Cytometry Practices for Immuno‐Oncology: A multifaceted challenge
- (2019) Tamara J. Laskowski et al. CYTOMETRY PART A
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- (2019) Andrea Cossarizza et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors
- (2018) Fresia Pareja et al. Nature Communications
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Simultaneous epitope and transcriptome measurement in single cells
- (2017) Marlon Stoeckius et al. NATURE METHODS
- Mass Cytometry: Single Cells, Many Features
- (2016) Matthew H. Spitzer et al. CELL
- Novel technologies and emerging biomarkers for personalized cancer immunotherapy
- (2016) Jianda Yuan et al. Journal for ImmunoTherapy of Cancer
- Checkpoints
- (2015) James P. Allison CELL
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Immune monitoring technology primer: flow and mass cytometry
- (2015) Holden T. Maecker et al. Journal for ImmunoTherapy of Cancer
- Developments in the immunophenotypic analysis of haematological malignancies
- (2013) Kathy Heel et al. BLOOD REVIEWS
- Visible and near infrared fluorescence spectral flow cytometry
- (2012) John P. Nolan et al. CYTOMETRY PART A
- From single cells to deep phenotypes in cancer
- (2012) Sean C Bendall et al. NATURE BIOTECHNOLOGY
- Defining the critical hurdles in cancer immunotherapy
- (2011) Bernard A Fox et al. Journal of Translational Medicine
- Cytometry in cell necrobiology revisited. Recent advances and new vistas
- (2010) Donald Wlodkowic et al. CYTOMETRY PART A
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started